Alopecia Areata: Autoimmune Mechanism, Diagnosis and 2026 Treatments
Alopecia areata affects approximately 2% of the world population and is radically different from androgenetic alopecia. Unlike the latter — caused by DHT and genetics — areata is an autoimmune disease that can occur at any age, even in children.
What Is Alopecia Areata?
Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles as if they were foreign bodies. The result: patchy hair loss, often circular, which can progress to total loss.
Unlike androgenetic alopecia, the follicles are not destroyed — they are simply dormant due to inflammation. Spontaneous regrowth is possible in many cases, but remains unpredictable.
The Biological Mechanism
Hair follicles normally benefit from immune privilege. In areata, this privilege is lost. Cytotoxic T lymphocytes infiltrate around the hair bulb and block the anagen growth cycle, causing sudden patchy hair loss.
The 3 Clinical Forms
- Localized areata: one or more rounded bald patches. Most common form (80% of cases). Spontaneous regrowth in 50-80% of cases.
- Alopecia totalis: total loss of scalp hair. More guarded prognosis.
- Alopecia universalis: loss of all body hair including eyebrows and eyelashes. Most severe form.
Diagnosis
Diagnosis is primarily clinical: smooth patches without scaling, exclamation mark hairs, positive pull test at patch borders, and characteristic dermoscopy findings. A blood panel may look for associated autoimmune conditions.
2026 Available Treatments
Corticosteroids
First-line treatment for localized forms. Intralesional triamcinolone injections every 4-6 weeks. Efficacy: 60-70% for limited forms.
Minoxidil
Topical 5% minoxidil can stimulate regrowth, especially combined with corticosteroids. Non-curative — acts on the shedding symptom.
JAK Inhibitors — The 2023-2026 Revolution
The genuine therapeutic breakthrough. Baricitinib (Olumiant) and ritlecitinib (Litfulo) are the first systemic treatments specifically approved for severe alopecia areata. In clinical trials, 30-40% of patients recovered more than 80% of their hair coverage in 36 weeks.
Contact Immunotherapy (DPCP)
Used for extensive refractory forms. Variable efficacy: 30-50%.
Is Hair Transplant Possible?
During an active phase of alopecia areata, FUE transplant is contraindicated. The immune system will attack implanted grafts exactly as it attacks native follicles, resulting in total graft loss.
In forms stabilized for more than 2 years with definitive scar zones, a transplant may be considered following a complete immunological assessment.
Think you might have alopecia areata or want to know if a transplant is right for your case? Phoenix Hair Center experts offer free guidance to the appropriate specialist.
